Antti Arjonen

1.8k total citations
20 papers, 1.4k citations indexed

About

Antti Arjonen is a scholar working on Cell Biology, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Antti Arjonen has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cell Biology, 12 papers in Immunology and Allergy and 10 papers in Molecular Biology. Recurrent topics in Antti Arjonen's work include Cell Adhesion Molecules Research (12 papers), Cellular transport and secretion (7 papers) and Cellular Mechanics and Interactions (7 papers). Antti Arjonen is often cited by papers focused on Cell Adhesion Molecules Research (12 papers), Cellular transport and secretion (7 papers) and Cellular Mechanics and Interactions (7 papers). Antti Arjonen collaborates with scholars based in Finland, United Kingdom and Germany. Antti Arjonen's co-authors include Johanna Ivaska, Teijo Pellinen, Riina Kaukonen, Karoliina Vuoriluoto, Jonna Alanko, Stefan Veltel, Jack Fransen, Elina Mattila, Jonna Nevo and Juha Rantala and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Cell Biology and Nature Cell Biology.

In The Last Decade

Antti Arjonen

20 papers receiving 1.4k citations

Peers

Antti Arjonen
Emanuel Rognoni United Kingdom
Silvia M. Goicoechea United States
David S. Harburger United States
Maaike Kreft Netherlands
Nicholas O. Deakin United States
Xinzi Yu United Kingdom
Paola A. Castagnino United States
Yangmi Lim South Korea
Emanuel Rognoni United Kingdom
Antti Arjonen
Citations per year, relative to Antti Arjonen Antti Arjonen (= 1×) peers Emanuel Rognoni

Countries citing papers authored by Antti Arjonen

Since Specialization
Citations

This map shows the geographic impact of Antti Arjonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antti Arjonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antti Arjonen more than expected).

Fields of papers citing papers by Antti Arjonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antti Arjonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antti Arjonen. The network helps show where Antti Arjonen may publish in the future.

Co-authorship network of co-authors of Antti Arjonen

This figure shows the co-authorship network connecting the top 25 collaborators of Antti Arjonen. A scholar is included among the top collaborators of Antti Arjonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antti Arjonen. Antti Arjonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arjonen, Antti, et al.. (2024). Spatial Engineering of Mammary Epithelial Cell Cultures with 3D Bioprinting Reveals Growth Control by Branch Point Proximity. Journal of Mammary Gland Biology and Neoplasia. 29(1). 5–5. 3 indexed citations
2.
Mäkelä, Rami, Antti Arjonen, Ville Härmä, et al.. (2021). Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma. Frontiers in Oncology. 11. 735820–735820. 4 indexed citations
3.
Arjonen, Antti, Rami Mäkelä, Ville Härmä, et al.. (2020). Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma. Lung Cancer. 145. 27–32. 17 indexed citations
4.
Mäkelä, Rami, Antti Arjonen, Aldwin Suryo Rahmanto, et al.. (2020). Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma. Neoplasia. 22(9). 390–398. 8 indexed citations
5.
Mäkelä, Rami, Antti Arjonen, Ville Härmä, et al.. (2020). Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma. BMC Cancer. 20(1). 590–590. 11 indexed citations
6.
Rantala, Juha, Antti Arjonen, Heikki Hakkarainen, et al.. (2020). Ex Vivo Modelling of Therapy Efficacy for Rare Krukenberg Tumors – A Report of Two Cases. 1–8. 2 indexed citations
7.
Sahgal, Pranshu, Jonna Alanko, Jaroslav Icha, et al.. (2019). GGA2 and RAB13 promote activity-dependent β1-integrin recycling. Journal of Cell Science. 132(11). 31 indexed citations
8.
Franceschi, Nicola De, Antti Arjonen, Nadia Elkhatib, et al.. (2016). Selective integrin endocytosis is driven by interactions between the integrin α-chain and AP2. Nature Structural & Molecular Biology. 23(2). 172–179. 54 indexed citations
9.
Kärnä, Riikka, et al.. (2015). Cell protrusions induced by hyaluronan synthase 3 (HAS3) resemble mesothelial microvilli and share cytoskeletal features of filopodia. Experimental Cell Research. 337(2). 179–191. 27 indexed citations
10.
Wang, Ying, Antti Arjonen, Jeroen Pouwels, et al.. (2015). Formin-like 2 Promotes β1-Integrin Trafficking and Invasive Motility Downstream of PKCα. Developmental Cell. 34(4). 475–483. 42 indexed citations
11.
Arjonen, Antti, Riina Kaukonen, Elina Mattila, et al.. (2014). Mutant p53–associated myosin-X upregulation promotes breast cancer invasion and metastasis. Journal of Clinical Investigation. 124(3). 1069–1082. 134 indexed citations
12.
Knapp, Bettina L., Dorota Matelska, Antti Arjonen, et al.. (2014). RNAi screen identifies KIF15 as a novel regulator of integrin endocytic trafficking. Journal of Cell Science. 127(Pt 11). 2433–47. 24 indexed citations
13.
Arjonen, Antti, Jonna Alanko, Stefan Veltel, & Johanna Ivaska. (2012). Distinct Recycling of Active and Inactive β1 Integrins. Traffic. 13(4). 610–625. 181 indexed citations
14.
Arjonen, Antti, Jonna Alanko, Stefan Veltel, & Johanna Ivaska. (2012). 485 Distinct Recycling of Active and Inactive 1 Integrins. European Journal of Cancer. 48. S116–S117. 3 indexed citations
15.
Pellinen, Teijo, Juha Rantala, Antti Arjonen, et al.. (2012). A functional genetic screen reveals new regulators of β1-integrin activity. Journal of Cell Science. 125(3). 649–661. 33 indexed citations
16.
Arjonen, Antti, Riina Kaukonen, & Johanna Ivaska. (2011). Filopodia and adhesion in cancer cell motility. Cell Adhesion & Migration. 5(5). 421–430. 204 indexed citations
17.
Arjonen, Antti, et al.. (2010). PtdIns(3,4,5)P3 is a regulator of myosin-X localization and filopodia formation. Journal of Cell Science. 123(20). 3525–3534. 69 indexed citations
18.
Pellinen, Teijo, Saara Hämälistö, Antti Arjonen, et al.. (2008). Integrin Trafficking Regulated by Rab21 Is Necessary for Cytokinesis. Developmental Cell. 15(3). 371–385. 159 indexed citations
19.
Pellinen, Teijo, et al.. (2006). Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of β1-integrins. The Journal of Cell Biology. 173(5). 767–780. 267 indexed citations
20.
Mattila, Elina, Teijo Pellinen, Jonna Nevo, et al.. (2004). Negative regulation of EGFR signalling through integrin-α1β1-mediated activation of protein tyrosine phosphatase TCPTP. Nature Cell Biology. 7(1). 78–85. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026